Plas­tic from blood­meal

Re­search by a Univer­sity of Waikato sci­en­tist into how to turn blood­meal into biodegrad­able plas­tic has won in­vest­ment from the Wal­lace Cor­po­ra­tion, New Zealand’s largest ser­vice ren­der­ing busi­ness.

Element - - WORLD -

Hamil­ton-based Aduro Biopoly­mers is a spin-off com­pany formed by Waika­toLink Lim­ited, the tech­nol­ogy trans­fer of­fice of the Univer­sity of Waikato, and was formed to de­velop and mar­ket ma­te­ri­als and biopoly­mers for use in the man­u­fac­tur­ing sec­tor. The com­pany is cur­rently de­vel­op­ing a novel ma­te­rial based on an un­con­ven­tional idea devel­oped by Univer­sity of Waikato sci­en­tist Dr Jo­han Ver­beek; turn­ing blood­meal into bio­plas­tic.

Aduro Poly­mers’ aim is to de­velop en­vi­ron­men­tally con­scious ma­te­ri­als for the man­u­fac­tur­ing and con­struc­tion sec­tors. The com­pany’s first prod­uct is No­vatein, a bio­plas­tic that will be price com­pet­i­tive with petro­chem­i­cal plas­tics. The global plas­tics mar­ket is worth over a tril­lion dol­lars and cur­rently bio­plas­tics rep­re­sent 5-10% of that mar­ket, with a com­pounded an­nual growth rate of al­most 20%.

Newspapers in English

Newspapers from New Zealand

© PressReader. All rights reserved.